Spyre Therapeutics (SYRE) Other Non-Current Liabilities (2015 - 2026)
Spyre Therapeutics (SYRE) reported Other Liabilities of $14.81 million for Q3 2026, up 358.5% from $3.23 million a year earlier but down 68.6% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics posted Other Liabilities of $30.54 million, down 68.9% from FY2024.
- Other Liabilities has a five-year compound annual growth rate of 169.7% (FY2020 to FY2025).
- By year, Other Liabilities came in at $98.32 million in FY2024 (+138.0%), $41.31 million in FY2023 and $16,000 in FY2021 (-92.5%).
- Five-year quarterly Other Liabilities spans a low of $8,000 in Q1 2022 and a high of $98.32 million in Q4 2024.
- Year over year, Other Liabilities gained in three of the last six quarters, with growth averaging 95.4%.
- The high point for year-over-year Other Liabilities in five years was Q3 2026 (growth of 358.5%); the low point was Q1 2022 (a decline of 96.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $47.18 million (Q2 2026), $64.93 million (Q1 2026) and $30.54 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.81 Mn |
| Jun 30, 2026 | 47.18 Mn |
| Mar 31, 2026 | 64.93 Mn |
| Dec 31, 2025 | 30.54 Mn |
| Sep 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 16.49 Mn |
| Dec 31, 2024 | 98.32 Mn |
| Sep 30, 2024 | 36.16 Mn |
| Jun 30, 2024 | 39.56 Mn |
| Mar 31, 2024 | 39.11 Mn |
| Dec 31, 2023 | 41.31 Mn |
| Sep 30, 2023 | 20.69 Mn |
| Jun 30, 2023 | 19.00 Mn |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 192,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 206,000.00 |
| Dec 31, 2020 | 214,000.00 |
| Sep 30, 2020 | 61,000.00 |
API Access
Spyre Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();